MX2010002025A - Secuencias y composiciones peptidicas. - Google Patents
Secuencias y composiciones peptidicas.Info
- Publication number
- MX2010002025A MX2010002025A MX2010002025A MX2010002025A MX2010002025A MX 2010002025 A MX2010002025 A MX 2010002025A MX 2010002025 A MX2010002025 A MX 2010002025A MX 2010002025 A MX2010002025 A MX 2010002025A MX 2010002025 A MX2010002025 A MX 2010002025A
- Authority
- MX
- Mexico
- Prior art keywords
- sequences
- polypeptides
- protein
- vertebrate
- polypeptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 239000000203 mixture Substances 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 241000238421 Arthropoda Species 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 2
- 210000003296 saliva Anatomy 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000013519 translation Methods 0.000 abstract 1
- 230000014616 translation Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/005—Trypanosoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/806—Antigenic peptides or proteins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/858—Proteins from animals other than mammals or birds insects; venom
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se proporciona una composición polipeptídica que comprende uno o más polipéptidos, polipéptidos los cuales son inmunogénicos en un vertebrado de modo que hace que el vertebrado produzca células del sistema inmune capaces de reconocer al menos un epítope de una fracción de proteína de saliva de artrópodo, donde la fracción de proteína de saliva tiene una masa de 40kDa o menos, y donde los polipéptidos son seleccionados independientemente de:las secuencias polipeptídicas de SEQ ID 1-44 o subsecuencias de esas secuencias, las subsecuencias tienen 7 aminoácidos o más; ode las secuencias polipeptídicas que tienen una homología del 85% o más con una o más de las secuencias anteriores y contenidas en una o más de las siguientes bases de datos: GenBank, Protein Data Bank (PDB), SwissProt, Protein Information Resource, (PIR), protein Research Foundation (PRF), y traducciones de CDS de esas.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0717864.3A GB0717864D0 (en) | 2007-09-13 | 2007-09-13 | Peptide sequences and compositions |
| PCT/EP2008/061824 WO2009034041A2 (en) | 2007-09-13 | 2008-09-05 | Peptide sequences and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010002025A true MX2010002025A (es) | 2010-03-15 |
Family
ID=38658898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010002025A MX2010002025A (es) | 2007-09-13 | 2008-09-05 | Secuencias y composiciones peptidicas. |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US8986703B2 (es) |
| EP (4) | EP2567706A3 (es) |
| JP (3) | JP2010539127A (es) |
| CN (1) | CN101815526B (es) |
| AR (1) | AR068428A1 (es) |
| AU (1) | AU2008297213B2 (es) |
| BR (1) | BRPI0816330A2 (es) |
| CA (1) | CA2699467A1 (es) |
| CL (1) | CL2008002727A1 (es) |
| CO (1) | CO6270336A2 (es) |
| DK (1) | DK2783694T3 (es) |
| ES (1) | ES2670859T3 (es) |
| GB (1) | GB0717864D0 (es) |
| HU (1) | HUE038953T2 (es) |
| MX (1) | MX2010002025A (es) |
| NO (1) | NO2783694T3 (es) |
| PE (1) | PE20090682A1 (es) |
| PL (1) | PL2783694T3 (es) |
| PT (1) | PT2783694T (es) |
| RU (1) | RU2466737C2 (es) |
| SG (1) | SG187401A1 (es) |
| TR (1) | TR201807414T4 (es) |
| TW (1) | TWI548646B (es) |
| WO (1) | WO2009034041A2 (es) |
| ZA (1) | ZA201000914B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101048181A (zh) * | 2004-08-13 | 2007-10-03 | 巴里·J·马沙尔 | 细菌递送系统 |
| EP2191849B1 (en) * | 2007-09-26 | 2018-08-01 | National Cerebral and Cardiovascular Center | Drug for suppressing pathogen occurring in vivo |
| US8012466B2 (en) * | 2008-01-31 | 2011-09-06 | University Of Iowa Research Foundation | Immunogenic compositions for activating γδ T cells |
| JP5344558B2 (ja) * | 2008-10-31 | 2013-11-20 | 国立大学法人 東京医科歯科大学 | カチオン性ナノゲルを用いる粘膜ワクチン |
| FR2955393B1 (fr) * | 2010-01-18 | 2015-12-11 | Inst Rech Developpement Ird | Methode pour evaluer l'efficacite de strategies de lutte anti-vectorielle dans le controle du paludisme et des arboviroses |
| KR101297037B1 (ko) * | 2010-03-26 | 2013-08-14 | 숙명여자대학교산학협력단 | 혈관신생촉진용 펩타이드 및 이의 용도 |
| US9701729B2 (en) | 2013-03-08 | 2017-07-11 | Taiho Pharmaceutical Co., Ltd. | Peptide having 5 linked CTL epitopes |
| JP6406647B2 (ja) * | 2013-07-02 | 2018-10-17 | 公益財団法人がん研究会 | 細胞性免疫誘導ワクチン |
| RU2636549C1 (ru) | 2013-10-21 | 2017-11-23 | Тайхо Фармасьютикал Ко., Лтд. | Новый пептид, имеющий 4 связанных ctl-эпитопа |
| CN104356216B (zh) * | 2014-10-09 | 2017-03-01 | 昆明医科大学 | 版纳绳蚋防御肽SibaDef及其基因和应用 |
| WO2016126457A1 (en) * | 2015-02-02 | 2016-08-11 | Yale University | Mosquito saliva protein malaria vaccine |
| US10570194B2 (en) | 2015-08-06 | 2020-02-25 | Grifols Worldwide Operations Limited | Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM) |
| US9913903B2 (en) | 2015-08-06 | 2018-03-13 | Grifols Worldwide Operations Limited | Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM |
| JP6893765B2 (ja) * | 2016-07-15 | 2021-06-23 | 森山 雅美 | 人以外の陸上動物用のウイルス感染症に対する抗体誘導剤とその補助剤 |
| CN107236028B (zh) * | 2017-07-05 | 2020-12-04 | 贵州医科大学 | 白纹伊蚊唾液34K2重组蛋白在DENV2感染HaCaT细胞中的应用 |
| TWI805792B (zh) | 2018-06-29 | 2023-06-21 | 日商大鵬藥品工業股份有限公司 | 抗腫瘤劑及其評估方法 |
| EP4013411A4 (en) * | 2019-08-13 | 2023-08-16 | Tata Consultancy Services Limited | PREDIABETES RISK ASSESSMENT SYSTEM AND METHODOLOGY |
| US20220290248A1 (en) * | 2019-08-13 | 2022-09-15 | Tata Consultancy Services Limited | System and method for assessing the risk of colorectal cancer |
| KR102615021B1 (ko) * | 2021-10-14 | 2023-12-20 | 주식회사 메디트 | 3차원 스캐너의 스캔 이미지 정렬 방법, 장치 및 명령을 기록한 기록매체 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004039958A2 (en) | 2002-10-29 | 2004-05-13 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Lutzomyia longipalpis polypeptides and methods of use |
-
2007
- 2007-09-13 GB GBGB0717864.3A patent/GB0717864D0/en not_active Ceased
-
2008
- 2008-09-05 PT PT141629253T patent/PT2783694T/pt unknown
- 2008-09-05 TR TR2018/07414T patent/TR201807414T4/tr unknown
- 2008-09-05 JP JP2010524469A patent/JP2010539127A/ja active Pending
- 2008-09-05 CA CA2699467A patent/CA2699467A1/en not_active Abandoned
- 2008-09-05 WO PCT/EP2008/061824 patent/WO2009034041A2/en not_active Ceased
- 2008-09-05 SG SG2012095782A patent/SG187401A1/en unknown
- 2008-09-05 CN CN200880106321.2A patent/CN101815526B/zh not_active Expired - Fee Related
- 2008-09-05 US US12/677,682 patent/US8986703B2/en not_active Ceased
- 2008-09-05 NO NO14162925A patent/NO2783694T3/no unknown
- 2008-09-05 AU AU2008297213A patent/AU2008297213B2/en active Active
- 2008-09-05 BR BRPI0816330 patent/BRPI0816330A2/pt not_active Application Discontinuation
- 2008-09-05 EP EP12177189.3A patent/EP2567706A3/en not_active Withdrawn
- 2008-09-05 MX MX2010002025A patent/MX2010002025A/es active IP Right Grant
- 2008-09-05 HU HUE14162925A patent/HUE038953T2/hu unknown
- 2008-09-05 DK DK14162925.3T patent/DK2783694T3/en active
- 2008-09-05 EP EP11178673A patent/EP2407172A1/en not_active Withdrawn
- 2008-09-05 PL PL14162925T patent/PL2783694T3/pl unknown
- 2008-09-05 RU RU2010114597/15A patent/RU2466737C2/ru active IP Right Revival
- 2008-09-05 US US15/469,016 patent/USRE47222E1/en active Active
- 2008-09-05 EP EP08803793A patent/EP2182972A2/en not_active Withdrawn
- 2008-09-05 EP EP14162925.3A patent/EP2783694B1/en active Active
- 2008-09-05 ES ES14162925.3T patent/ES2670859T3/es active Active
- 2008-09-10 TW TW097134650A patent/TWI548646B/zh not_active IP Right Cessation
- 2008-09-12 AR ARP080103971A patent/AR068428A1/es not_active Application Discontinuation
- 2008-09-12 CL CL2008002727A patent/CL2008002727A1/es unknown
- 2008-09-15 PE PE2008001614A patent/PE20090682A1/es not_active Application Discontinuation
-
2010
- 2010-02-08 ZA ZA2010/00914A patent/ZA201000914B/en unknown
- 2010-04-13 CO CO10042686A patent/CO6270336A2/es not_active Application Discontinuation
-
2013
- 2013-06-10 JP JP2013122060A patent/JP5981883B2/ja active Active
-
2016
- 2016-01-04 JP JP2016000251A patent/JP6227018B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010002025A (es) | Secuencias y composiciones peptidicas. | |
| NZ597923A (en) | Protein glycosylation | |
| PE20120358A1 (es) | Mutantes fgf21 y usos de los mismos | |
| BRPI0412799A (pt) | imunógeno, composição, ácido nucleico, célula recombinante, métodos para preparar um polipeptìdeo, para induzir um a resposta imune protetora em um paciente e para induzir uma resposta anamnésica em um paciente, e, seqüência de ácido nucleico otimizada de levedura | |
| CA2563675A1 (en) | Recombinantly modified plasmin | |
| NZ596981A (en) | Compositions and methods for the treatment of tumor of hematopoietic origin | |
| Sanz et al. | Molecular cloning of disintegrins from Cerastes vipera and Macrovipera lebetina transmediterranea venom gland cDNA libraries: insight into the evolution of the snake venom integrin-inhibition system | |
| Evans Jr et al. | Helicobacter pylori CagA: analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor | |
| BRPI0511429A (pt) | proteìna de ligação à fibronectina (fnb) isolada, alterada de staphylococcal aureus (s. aureus); fnb isolada, alterada; composição imunogênica; método para imunizar um vertebrado contra s. aureus; vetor de expressão; célula hospedeira recombinante; método para produzir uma fnb alterada; método para induzir uma resposta imunológica em um vertebrado; proteìna isolada, alterada de ligação à fibronectina (fnb) de staphylococcal aureus (s. aureus); e molécula isolada de ácido nucléico que codifica uma fnb alterada de s. aureus | |
| Shibata et al. | Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide | |
| Kawaguchi et al. | Conservation of the egg envelope digestion mechanism of hatching enzyme in euteleostean fishes | |
| NZ591133A (en) | Novel melanoma antigen peptide and uses thereof | |
| Soni et al. | Peptides Containing meso‐Oxa‐Diaminopimelic Acid as Substrates for the Cell‐Shape‐Determining Proteases Csd6 and Pgp2 | |
| ATE357526T1 (de) | Modifizierte hcv peptid-impfstoffe | |
| WO2008155363A3 (en) | Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof | |
| Brinkworth et al. | Structural analysis of the catalytic site of AcCP-1, a cysteine proteinase secreted by the hookworm Ancylostoma caninum | |
| Tomkinson et al. | The insert within the catalytic domain of tripeptidyl‐peptidase II is important for the formation of the active complex | |
| Ota et al. | Molecular cloning of two toxic phospholipases A2 from the crown-of-thorns starfish Acanthaster planci venom | |
| TH124682A (th) | ลำดับเพพไทด์และองค์ประกอบ | |
| Matsuo et al. | Cloning and expression of the ferredoxin gene from extremely halophilic archaeon Haloarcula japonica strain TR-1 | |
| Shen et al. | Subunit interaction and regulation of activity through terminal domains of the family D DNA polymerase from Pyrococcus horikoshii | |
| Barzik et al. | Crystallization and preliminary X-ray analysis of the EVH1 domain of Vesl-2b | |
| WO2006090282A3 (en) | Recombinant inhibitor proteins of an hk14 protease and use thereof | |
| DE602005016417D1 (de) | Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila | |
| WO2004009775A3 (en) | Methods and compositions relating to chimeric nicotinic receptor subunits |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |